Form 4 for EW Edwards Lifesciences
Accepted 2026-05-08 21:16:34 ET · period of report 2026-05-07 · accession 0001225208-26-005047 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-05-08 21:16 | 2026-05-07+ | EW | Ullem Scott B. | CFO, CVP | F - Tax | $82.96 | -3,034 | 37.9K | -7% | -$251.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-07 | F | D | 1,373 | $83.20 | 39,575 | D | — | — | |
| 2 | Common | Common Stock | 2026-05-08 | F | D | 1,661 | $82.76 | 37,914 | D | — | — |